Increased Number of Shares and Votes in Kinnevik
Kinnevik AB (publ) ("Kinnevik") today announced that as of 30 November 2021 the total number of shares in the company amounts to 278,697,215, and the total number of votes in the company amounts to 582,496,103.
The increase is due to the new issue of 853,550 reclassifiable, sub-ordinated, incentive shares of classes C 2021 and D 2021, which, in accordance with the resolutions by the Extraordinary General Meeting in October 2021, have been transferred to participants in Kinnevik's 2021 long-term share incentive plan. During November Kinnevik also has also redeemed 76,900 reclassifiable, sub-ordinated incentive shares held by former participants in Kinnevik's long-term share incentive plans resolved by the 2019 and 2020 Annual General Meetings, respectively.
As of 30 November 2021, the total number of shares in Kinnevik are divided into two classes of ordinary shares and ten classes of incentive shares as follows:
- 33,755,432 ordinary shares of class A with ten votes each and 242,153,584 ordinary shares of class B with one vote each, and
- 297,258 incentive shares of class G 2018, 39,158 incentive shares of class D 2019, 113,292 incentive shares of class E 2019, 113,292 incentive shares of class F 2019, 379,312 incentive shares of class G 2019, 53,242 incentive shares of class C1 2020, 309,480 incentive shares of class C2 2020, 629,615 incentive shares of class D 2020, 426,775 incentive shares of class C 2021, and 426.775 incentice shares of class D 2021 with one vote each (of which Kinnevik holds 9,975 incentive shares of class C 2021 and 9,975 incentive shares of class D 2021 in treasury).
This information is of such character, which Kinnevik AB (publ) shall disclose in accordance with the Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was distributed for disclosure, through the agency of the contact person set out below, at 08:00 CET on 30 November 2021.
For further information, visit www.kinnevik.com or contact:
Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Kinnevik's ambition is to be Europe's leading listed growth investor, and we back the best digital companies for a reimagined everyday and to deliver significant returns. We understand complex and fast-changing consumer behaviours, and have a strong and expanding portfolio in healthtech, consumer services, foodtech and fintech. As a long-term investor, we strongly believe that investing in sustainable business models and diverse teams will bring the greatest returns for shareholders. We back our companies at every stage of their journey and invest in Europe, with a focus on the Nordics, and in the US. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik's shares are listed on Nasdaq Stockholm's list for large cap companies under the ticker codes KINV A and KINV B.
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Galapagos creates new subscription right plan26.1.2022 22:40:00 CET | Press release
Mechelen, Belgium; 26 January 2022, 22.40 CET; regulated information – GalapagosNV (Euronext & NASDAQ: GLPG) announced today that its supervisory board created 1,000,000subscription rights under a new subscription right plan for the benefit of a member of the personnel of the Company. On 26 January 2022, the supervisory board of Galapagos approved “Subscription Right Plan 2022 (B)”, intended for a new member of the personnel of the Company, within the framework of the authorized capital. Under this subscription right plan, 1,000,000 subscription rights were created, subject to acceptance. Dr. Paul Stoffels will ultimately become the new Subscription Right Holder under the scheme. The subscription rights have an exercise term of eight years as of the date of the offer and have an exercise price of €50. The subscription rights can in principle not be exercised prior to 1 January 2026. Each subscription right gives the right to subscribe to one new Galapagos share. Should the subscription
Galapagos appoints Paul Stoffels as Chief Executive Officer26.1.2022 22:01:00 CET | Press release
Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirementRecognized as inspirational industry leader with exceptional R&D as well as global executive experience, and a strong focus on bringing innovative medicines to patientsOutstanding track record of accelerated product development in biotech and pharma through insightful acquisitions and strategic partnerships Mechelen, Belgium;26January 2022, 22.01CET;regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) is pleased to announce the appointment of Dr. Paul Stoffelsas Chief Executive Officer (CEO),effective April 1, 2022.Dr. Stoffelsbrings an impressive track record of success in innovative drug discovery and development,and a wealth of experience in biotech and pharma, across a range of roles and therapeutic areas. “After a rigorous selection process, we are very pleased to announce Paul as our next CEO. Given his extraordinary R&D as well as managerial experience, extensive net
XBiotech Announces First Patient Enrolled in Phase I Clinical Trial for Novel Arthritis Therapy Natrunix-SQ26.1.2022 15:50:37 CET | Press release
Natrunix-SQ, A True Human Antibody Therapy Discovered and Manufactured at XBiotech, Is Aimed as a Breakthrough Treatment for Arthritic Disease AUSTIN, Texas, Jan. 26, 2022 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) enrolled the first patient in a randomized, double-blind, placebo-controlled clinical study to evaluate safety and pharmacokinetics of Natrunix-SQ. Natrunix-SQ targets a crucial inflammatory pathway involved in pain and joint destruction in various forms of arthritis. XBiotech believes that Natrunix-SQ may be the most effective means of blocking the inflammatory pathway involved in arthritis and thus could represent a breakthrough treatment for arthritides. The Phase I study represents the launch of the clinical program for Natrunix-SQ for the treatment of rheumatological diseases. The Phase I study will evaluate Natrunix-SQ blood levels in the context of increasing doses. These findings will guide follow-up studies with Natrunix-SQ. Upon successful completion of the P
Real People Investment Holdings Limited changes its name to Evolution Credit Limited26.1.2022 14:30:00 CET | Press release
Real People Investment Holdings Limited (the "Company") has changed its name to Evolution Credit Limited. In connection with the Company's name change, the Real People group will rebrand its Real People Home Improvement Finance business to Evolution Finance and Real People Life will become Evolution Life. The rebranding will not include the debt collection business DMC Debt Management. The Company's NOK Bonds with ISIN NO0010689342 and SEK Bonds with ISIN SE0005392560 admitted to trading on Nasdaq First North Bond Market will continue to be traded under their existing short names RPIH NOK and RPIH SEK, respectively. As from 28 January 2022, the address of the Company's web page will be www.evolution.za.com. For further information, please contact: Carmen Taylor, Head of Governance and Secretarial +27 82 772 5481, firstname.lastname@example.org Attachment Real People Investment Holdings Limited - Press release re. name change
MCH Group | Ad hoc announcement pursuant to Art. 53 LR | New art fair in Paris26.1.2022 12:30:00 CET | Press release
Art Basel selected to stage new contemporary art fair in Paris MCH Group Ltd., based in Basel/Switzerland, announces that Art Basel has been awarded a seven-year contract to stage a new contemporary art fair in Paris, following a public competition initiated by the "Réunion des musées nationaux – Grand Palais" in December last year. Launching in October 2022, the new art event will take place at the temporary venue "Grand Palais Éphémère" until the restoration of the "Grand Palais" is completed in 2024. Together with the "Réunion des musées nationaux – Grand Palais", Art Basel will strive to create a fair truly rooted in the twenty-first century that radiates throughout the city and is firmly embedded in Paris and its cultural and creative industries. MCH Group intends to establish a new French legal entity and employ a dedicated team on the ground. It is planed to develop an identity and a brand specific to the Parisian fair. "City Activation is a key element in our strategy," says Be
Change to the publication time of Talenom Plc's Financial Statements Bulletin 2021: the release will be published on 8 February 2022 at 9:00 EET26.1.2022 12:00:00 CET | Press release
Talenom Plc, Press release 26 January 2022 at 13:00 EET Change to the publication time of TalenomPlc's Financial Statements Bulletin 2021: the release will be published on 8 February 2022at 9:00 EET Talenom Plc's new publication time for its Financial Statements Bulletin for 2021 is at 9:00 EET on Tuesday 8 February 2022. The previously announced time was at 13:30 EET. The company's CEO Otto-Pekka Huhtala will present the main points of the review in a live webcast on Tuesday 8 February 2022 at 10:00 EET. The live webcast will be in Finnish, but a recording of the event will be published also in English on Talenom’s website https://sijoittajat.talenom.fi/en The live webcast event can be viewed at: https://talenom.videosync.fi/tilinpaatos-2021 Participants will have the opportunity to present questions during the briefing over the webcast platform. Due to the Covid-19 situation, the event is completely virtual. The presentation materials will be published before the start of the briefin
Maha Energy announce spud of Tie-526.1.2022 12:00:00 CET | Press release
Maha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce the spud of the Tie-5 Agua Grande (AG) horizontal well in Brazil. The Tie-5 well was spudded on time as per planned schedule at 0900 (GMT-3) on January 25th on the Tie field in Brazil. The well is designed as a horizontal well and will drain the northern part of the Tie field at the Agua Grande level. As communicated earlier, the Tie-4 well was completed as a vertical producer and tested 4,695 BOEPD on an Electrical Submersible Pump (ESP). The Tie-4 well is now producing through the Tie Production Facility. Jonas Lindvall, CEO of Maha Energy comments: ”In light of the very positive well performance of Tie-4, we are very excited to start drilling the Tie-5 well. Our drilling team in Brazil have significantly improved on the Tie-4 well design and I am confident that we will be able to land the well horizontally in the AG.” Significant changes have been made to the Tie-5 well design to address the drilling issues encou